DSS, Inc. - DSS STOCK NEWS

Aegis Capital Corp. has successfully concluded a $24 million upsized follow-on offering for Document Security Systems (NYSE American: DSS). This move is part of DSS's strategy to enhance its business segments focused on brand protection technology, blockchain security, and healthcare, among others. The company aims to leverage its innovative technologies in counterfeit deterrence and consumer engagement. DSS is led by Chairman Fai Chan, a veteran in corporate restructuring.

Document Security Systems (DSS) has successfully closed an upsized public offering, generating $24 million in gross proceeds. The company issued 6,666,666 shares at a price of $3.60 each, with plans to utilize the funds for developing new business lines, acquisition opportunities, and general corporate needs. Additionally, underwriters have a 45-day option to purchase up to 15% more shares, potentially raising total gross proceeds to approximately $27.6 million.

Document Security Systems, Inc. (DSS) announced an upsized public offering expected to raise approximately $24 million, selling 6,666,666 shares at $3.60 each. Proceeds will support the development of new business lines, acquisitions, and general corporate needs. There is a 45-day option for underwriters to purchase an additional 15% of shares, potentially raising total proceeds to $27.6 million. Aegis Capital Corp. is the sole bookrunner for this offering, which was registered with the SEC on January 19, 2021.

Document Security Systems (DSS) announced that its subsidiary, Impact BioMedical, has entered into an investment and distribution agreement with Nano9 Labs. This partnership aims to enhance DSS's product offerings by adding private-labeled nutraceutical lines to its existing portfolio, leveraging Nano9's advanced delivery technology for better bioavailability. DSS expects this collaboration to boost its direct marketing revenue significantly, especially in the U.S. and Asia. The nutraceutical market is projected to grow substantially, providing ample opportunity for DSS's expansion.

Document Security Systems (DSS) announced that its subsidiary, Impact BioMedical, received a notice of patent allowance for its 3F Biofragrance, a botanical-based insect repellent. The patent protects its method of use against mosquitoes, leveraging terpenes to affect insect receptors. The global insect repellent market is projected to reach $9.6 billion by 2026, indicating significant commercial potential for DSS's innovation. CEO Frank D. Heuszel highlighted the expanded intellectual property estate and the substantial long-term value for shareholders as the product moves toward commercialization.

Document Security Systems (NYSE American: DSS) announced a 10-year exclusive distribution agreement with BioMed Technology Asia Pacific Holdings Limited to market and distribute various probiotic products across key markets including the US, Canada, and South Korea. The company will also purchase shares in BioMed valued at approximately $630,000, allowing them to appoint a director on BioMed’s board. The global probiotics market, valued at $48 billion in 2018, is projected to grow at a CAGR of 6.9% through 2025, indicating potential revenue growth for DSS's subsidiary Impact BioMedical.

DSS, a multinational company, announces its rebranding to Alset, Inc., with a proposed ticker symbol change pending shareholder approval after December 8. This change reflects the company's expanded business operations beyond document security, including sectors like healthcare and real estate. Chairman Chan Heng Fai emphasizes a diversified portfolio aimed at profitability and shareholder value through mergers and acquisitions. DSS continues to experience growth in anti-counterfeiting and packaging solutions, alongside new high-margin opportunities in direct marketing and real estate.

Document Security Systems, Inc. (DSS) has promoted Todd D. Macko to interim Chief Financial Officer effective October 28, 2020. Macko, a Certified Public Accountant with over 25 years in corporate finance, will leverage his expertise in financial planning and mergers and acquisitions to advance DSS's strategic initiatives. Previously the Vice President of Finance at DSS, he has been integral in financial leadership and reporting. DSS focuses on brand protection, blockchain security, and other sectors, with plans for shareholders to benefit from future spin-offs of its subsidiaries.

Document Security Systems (DSS) reported a 59% revenue increase in Q3 2020, reaching $4.2 million. The company achieved net income of $5.4 million or $1.20 per share, a significant turnaround from a loss of $1.2 million in Q3 2019. Stockholders’ equity surged 496% to $73.3 million. Key developments include the acquisition of Impact BioMedical, a special dividend declaration, and a multi-year contract worth $3.2 million annually. DSS also launched the AuthentiGuard as a Service app and expanded its research initiatives.